Entropy Technologies LP Has $334,000 Position in Teleflex Incorporated $TFX

Entropy Technologies LP cut its stake in shares of Teleflex Incorporated (NYSE:TFX) by 66.7% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,793 shares of the medical technology company’s stock after selling 5,591 shares during the quarter. Entropy Technologies LP’s holdings in Teleflex were worth $334,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in TFX. Ruffer LLP acquired a new position in Teleflex during the 4th quarter worth approximately $5,154,000. Waterfront Wealth Inc. acquired a new stake in Teleflex in the fourth quarter valued at approximately $2,050,000. Eos Management L.P. bought a new stake in shares of Teleflex during the fourth quarter valued at approximately $3,763,000. Universal Beteiligungs und Servicegesellschaft mbH increased its holdings in shares of Teleflex by 227.5% during the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 27,822 shares of the medical technology company’s stock valued at $3,395,000 after acquiring an additional 19,327 shares in the last quarter. Finally, First Eagle Investment Management LLC raised its position in shares of Teleflex by 163.4% during the fourth quarter. First Eagle Investment Management LLC now owns 84,300 shares of the medical technology company’s stock worth $10,288,000 after purchasing an additional 52,300 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on TFX. UBS Group initiated coverage on Teleflex in a report on Tuesday. They issued a “neutral” rating and a $145.00 target price on the stock. Piper Sandler upgraded shares of Teleflex from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $140.00 to $160.00 in a research note on Monday, June 8th. Truist Financial restated a “hold” rating and set a $143.00 price objective (up from $135.00) on shares of Teleflex in a report on Monday, May 11th. BMO Capital Markets began coverage on shares of Teleflex in a research note on Wednesday, July 8th. They issued an “outperform” rating and a $159.00 price objective on the stock. Finally, Royal Bank Of Canada upgraded shares of Teleflex from a “sector perform” rating to an “outperform” rating and lifted their price objective for the company from $135.00 to $155.00 in a report on Friday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $147.70.

Teleflex Stock Performance

Shares of Teleflex stock opened at $132.34 on Friday. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $139.67. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82. The business has a 50 day moving average price of $130.88 and a 200-day moving average price of $121.26. The company has a market cap of $5.86 billion, a PE ratio of -5.80, a price-to-earnings-growth ratio of 1.00 and a beta of 0.82.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The company had revenue of $548.30 million for the quarter, compared to analysts’ expectations of $536.91 million. During the same quarter in the previous year, the firm earned $1.44 earnings per share. Teleflex’s quarterly revenue was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities analysts anticipate that Teleflex Incorporated will post 6.7 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th were issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend was Friday, May 22nd. Teleflex’s payout ratio is currently -5.96%.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.